<SEC-DOCUMENT>0000899243-19-025486.txt : 20191010
<SEC-HEADER>0000899243-19-025486.hdr.sgml : 20191010
<ACCEPTANCE-DATETIME>20191010205611
ACCESSION NUMBER:		0000899243-19-025486
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20191010
FILED AS OF DATE:		20191010
DATE AS OF CHANGE:		20191010

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SVF Endurance (Cayman) Ltd
		CENTRAL INDEX KEY:			0001782338
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39083
		FILM NUMBER:		191146931

	BUSINESS ADDRESS:	
		STREET 1:		C/O WALKERS CORPORATE LIMITED
		STREET 2:		27 HOSPITAL ROAD
		CITY:			GEORGE TOWN
		STATE:			E9
		ZIP:			KY1-9008
		BUSINESS PHONE:		345 814 4512

	MAIL ADDRESS:	
		STREET 1:		C/O WALKERS CORPORATE LIMITED
		STREET 2:		27 HOSPITAL ROAD
		CITY:			GEORGE TOWN
		STATE:			E9
		ZIP:			KY1-9008

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SB INVESTMENT ADVISERS (UK) LTD
		CENTRAL INDEX KEY:			0001731509
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39083
		FILM NUMBER:		191146932

	BUSINESS ADDRESS:	
		STREET 1:		69 GROSVENOR STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 3JW
		BUSINESS PHONE:		44 2076290431

	MAIL ADDRESS:	
		STREET 1:		69 GROSVENOR STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			W1K 3JW

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SOFTBANK VISION FUND (AIV M1) L.P.
		CENTRAL INDEX KEY:			0001755143
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39083
		FILM NUMBER:		191146933

	BUSINESS ADDRESS:	
		STREET 1:		251 LITTLE FALLS DRIVE
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19808
		BUSINESS PHONE:		650-562-8211

	MAIL ADDRESS:	
		STREET 1:		251 LITTLE FALLS DRIVE
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19808

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vir Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001706431
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				812730369
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		499 ILLINOIS STREET
		STREET 2:		SUITE 500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
		BUSINESS PHONE:		415-906-4324

	MAIL ADDRESS:	
		STREET 1:		499 ILLINOIS STREET
		STREET 2:		SUITE 500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94158
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2019-10-10</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001706431</issuerCik>
        <issuerName>Vir Biotechnology, Inc.</issuerName>
        <issuerTradingSymbol>VIR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001782338</rptOwnerCik>
            <rptOwnerName>SVF Endurance (Cayman) Ltd</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O WALKERS CORP LTD CAYMAN CORP CENTRE</rptOwnerStreet1>
            <rptOwnerStreet2>27 HOSPITAL ROAD</rptOwnerStreet2>
            <rptOwnerCity>GEORGETOWN, GRAND CAYMAN</rptOwnerCity>
            <rptOwnerState>E9</rptOwnerState>
            <rptOwnerZipCode>KY1-9008</rptOwnerZipCode>
            <rptOwnerStateDescription>CAYMAN ISLANDS</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001731509</rptOwnerCik>
            <rptOwnerName>SB INVESTMENT ADVISERS (UK) LTD</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>69 GROSVENOR STREET</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>LONDON</rptOwnerCity>
            <rptOwnerState>X0</rptOwnerState>
            <rptOwnerZipCode>W1K 3JW</rptOwnerZipCode>
            <rptOwnerStateDescription>UNITED KINGDOM</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001755143</rptOwnerCik>
            <rptOwnerName>SOFTBANK VISION FUND (AIV M1) L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>251 LITTLE FALLS DRIVE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>WILMINGTON</rptOwnerCity>
            <rptOwnerState>DE</rptOwnerState>
            <rptOwnerZipCode>19808</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series A-1 Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>15555555</value>
                    <footnoteId id="F1"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>6111111</value>
                    <footnoteId id="F1"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The Series A-1 Convertible Preferred Stock and the Series B Convertible Preferred Stock are each convertible into Vir Biotechnology, Inc. common stock, have no expiration date and will convert into common stock automatically upon completion of the issuer's initial public offering.</footnote>
        <footnote id="F2">SVF Endurance (Cayman) Limited is a wholly-owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (&quot;SVF&quot;). SB Investment Advisers (UK) Limited (&quot;SBIA UK&quot;) has been appointed as alternative investment fund manager (&quot;AIFM&quot;) and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments.  SBIA UK is wholly owned by SoftBank Group Corp.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Karen Ellerbe, Director of SVF Endurance (Cayman) Limited</signatureName>
        <signatureDate>2019-10-10</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Brian Wheeler, General Counsel of SB Investment Advisers (UK) Limited, manager of SoftBank Vision Fund (AIV M1) L.P.</signatureName>
        <signatureDate>2019-10-10</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>/s/ Brian Wheeler, General Counsel of SB Investment Advisers (UK) Limited</signatureName>
        <signatureDate>2019-10-10</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
